MARKET

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA
45.05
-1.24
-2.68%
After Hours: 45.05 0 0.00% 16:00 11/15 EST
OPEN
46.30
PREV CLOSE
46.29
HIGH
46.30
LOW
45.05
VOLUME
581.77K
TURNOVER
--
52 WEEK HIGH
48.76
52 WEEK LOW
34.10
TOTAL ASSET
157.87M
YTD YIELD
25.44%
1D
5D
1M
3M
1Y
5Y
1D
Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs
Seeking Alpha · 12h ago
The U.S. Shakes Up Global Pharma Supply Chains
Seeking Alpha · 3d ago
Global Pharma carries the most overweight allocations in Nov – according to BofA’s Global FMS
Seeking Alpha · 4d ago
Why Healthcare Investors Shouldn't Bank On Drug Pipelines
Seeking Alpha · 4d ago
Weekly Report: what happened at XPH last week (1104-1108)?
Weekly Report · 6d ago
What Trump's Win May Mean For The Markets And Economy
Seeking Alpha · 11/07 17:30
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?
Barchart · 11/06 09:12
Tuesday's ETF with Unusual Volume: XPH
NASDAQ · 11/05 17:47
More
Profile
Fund Name
SPDR® S&P Pharmaceuticals ETF
Inception Date
2006-06-19
Benchmark
S&P Pharms Select Industry TR USD
Advisor Company
SPDR State Street Global Advisors
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Keith Richardson, Karl Schneider